HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
HUT
801
Hut 8
HUT
$3.28B
|
KD
Kevin Dede
| $31.04 | $25 |
19%
downside
| Buy |
19 May ‘22
3 years ago |
|
802
Pyxis Tankers
PXS
$29.3M
|
MF
Magnus Fyhr
| $2.79 | $6 |
115%
upside
| Buy |
17 May ‘22
3 years ago |
|
803
SCYNEXIS
SCYX
$40.9M
|
OL
Oren Livnat
| $0.9750 | $8 |
721%
upside
| Buy |
13 May ‘22
3 years ago |
|
|
BRNS
804
Barinthus Biotherapeutics
BRNS
$44.8M
|
RS
Raghuram Selvaraju
| $1.10 | $22 |
1,900%
upside
| Buy |
13 May ‘22
3 years ago |
|
805
TORM
TRMD
$2.21B
|
MF
Magnus Fyhr
| $22.57 | $16 |
29%
downside
| Buy |
12 May ‘22
3 years ago |
|
|
AMRN
806
Amarin Corp
AMRN
$314M
|
AF
Andrew Fein
| $15.20 | $60 |
295%
upside
| Neutral |
5 May ‘22
3 years ago |
|
807
Versus Systems
VS
$10M
|
HI
Heiko Ihle
| $2.04 | $600 |
29,312%
upside
| Buy |
29 Apr ‘22
3 years ago |
|
808
Scorpio Tankers
STNG
$2.89B
|
MF
Magnus Fyhr
| $56.63 | $38 |
33%
downside
| Buy |
29 Apr ‘22
3 years ago |
|
809
Aldeyra Therapeutics
ALDX
$338M
|
AF
Andrew Fein
| $5.63 | $15 |
166%
upside
| Buy |
27 Apr ‘22
3 years ago |
|
810
Ardmore Shipping
ASC
$497M
|
MF
Magnus Fyhr
| $12.21 | $8.50 |
30%
downside
| Buy |
22 Apr ‘22
3 years ago |
|
811
Dentsply Sirona
XRAY
$2.74B
|
YC
Yi Chen
| $13.73 | $48 |
250%
upside
| Neutral |
22 Apr ‘22
3 years ago |
|
812
Scholar Rock
SRRK
$2.92B
|
MK
Michael King
| $30.33 | $24 |
21%
downside
| Buy |
23 Mar ‘22
3 years ago |
|
813
Energy Focus
EFOI
$13.5M
|
AD
Amit Dayal
| $2.47 | $42 |
1,600%
upside
| Buy |
18 Mar ‘22
3 years ago |
|
814
Aprea Therapeutics
APRE
$9.09M
|
AF
Andrew Fein
| $1.56 | $40 |
2,464%
upside
| Neutral |
16 Mar ‘22
3 years ago |
|
815
Disc Medicine
IRON
$2.09B
|
AF
Andrew Fein
| $60.09 | $2 |
97%
downside
| Neutral |
11 Mar ‘22
3 years ago |
|
816
Salarius Pharmaceuticals
SLRX
$2.32M
|
MK
Michael King
| $4.56 | $12,000 |
263,058%
upside
| Buy |
11 Mar ‘22
3 years ago |
|
817
Quince Therapeutics
QNCX
$88.1M
|
AF
Andrew Fein
| $1.64 | $15 |
815%
upside
| Buy |
9 Mar ‘22
3 years ago |
|
818
AnaptysBio
ANAB
$630M
|
MK
Michael King
| $22.53 | $46 |
104%
upside
| Buy |
8 Mar ‘22
3 years ago |
|
819
Agios Pharmaceuticals
AGIO
$2.07B
|
MK
Michael King
| $35.62 | $96 |
170%
upside
| Buy |
3 Mar ‘22
3 years ago |
|
|
AGEN
820
Agenus
AGEN
$157M
|
MK
Michael King
| $4.92 | $280 |
5,591%
upside
| Buy |
2 Mar ‘22
3 years ago |
|
821
Xencor
XNCR
$603M
|
MK
Michael King
| $8.45 | $55 |
551%
upside
| Buy |
24 Feb ‘22
3 years ago |
|
822
Exelixis
EXEL
$10.3B
|
MK
Michael King
| $38.16 | $42 |
10%
upside
| Buy |
18 Feb ‘22
3 years ago |
|
|
HURA
823
TuHURA Biosciences, Inc. Common Stock
HURA
$120M
|
MK
Michael King
| $2.39 | $5,250 |
219,565%
upside
| Buy |
20 Jan ‘22
3 years ago |
|
824
Biomea Fusion
BMEA
$109M
|
MK
Michael King
| $1.84 | $13 |
607%
upside
| Buy |
12 Jan ‘22
3 years ago |
|
825
Xilio Therapeutics
XLO
$38.5M
|
MK
Michael King
| $0.7426 | $36 |
4,748%
upside
| Buy |
10 Jan ‘22
3 years ago |
|